1. Home
  2. CMTL vs COEP Comparison

CMTL vs COEP Comparison

Compare CMTL & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Comtech Telecommunications Corp.

CMTL

Comtech Telecommunications Corp.

N/A

Current Price

$5.19

Market Cap

162.1M

Sector

Technology

ML Signal

N/A

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

N/A

Current Price

$12.60

Market Cap

100.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CMTL
COEP
Founded
1967
2017
Country
United States
United States
Employees
1385
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
162.1M
100.4M
IPO Year
2024
N/A

Fundamental Metrics

Financial Performance
Metric
CMTL
COEP
Price
$5.19
$12.60
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$6.00
N/A
AVG Volume (30 Days)
225.6K
28.1K
Earning Date
03-16-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$499,528,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.19
$6.32
52 Week High
$6.21
$21.41

Technical Indicators

Market Signals
Indicator
CMTL
COEP
Relative Strength Index (RSI) 47.14 52.34
Support Level $4.86 $10.83
Resistance Level $6.15 $13.53
Average True Range (ATR) 0.33 0.79
MACD -0.04 0.20
Stochastic Oscillator 39.25 70.51

Price Performance

Historical Comparison
CMTL
COEP

About CMTL Comtech Telecommunications Corp.

Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: